Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

While venous blood sampling can help gain understanding of patients’ health through phenolic compound analysis, this process ...

While the EU Commission seeks to reduce strategic dependencies, Europe continues to import nearly a third of its blood plasma ...

A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...

Participants in the highest BGAT quartile of this study had a hazard ratio for VTE risk of 2.12 compared with those in the lowest BGAT quartile after adjusting for age and sex characteristics.

The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...

The exponential interest in neurology blood-based biomarkers stems from the technical breakthroughs in testing brought about ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...

FDA approves first blood test for Alzheimer's detection. Simple blood draw replaces expensive scans and spinal taps.